Topline results from the SURPASS-CVOT trial reveal that once-weekly tirzepatide (Mounjaro) has a cardiovascular risk profile ...

One study found that a low level of fitness poses a greater risk of death over time than other traditional risk factors ...

A study published in BMJ Open has revealed that urinary tract infections (UTIs) may act as a trigger for myocardial ...

Andhra Pradesh government allocates ₹194 crore for 100 new primary health centres, focusing on rural healthcare infrastructure development.

Learn about Savithri's osteoporosis diagnosis, risk factors, prevention, and the impact of fractures on the elderly ...

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in ...

Arterial hypertension (high blood pressure) is one of the leading causes of cardiovascular disease and mortality worldwide.

A 58-year-old man presents for a routine annual physical. During the exam, he mentions an intermittent sensation like a “rush of anxiety” that begins in the abdomen and chest and radiates to the head.

Posters presented at the ASPC 2025 Congress on Cardiac Prevention showed the benefit of participating in cardiac rehabilitation for a variety of cardiac issues.

BROCK LESNAR has RETURNED to WWE for the first time in TWO YEARS at SummerSlam. The Beast Incarnate took out former WWE ...

Exclusive: GPs are coming under pressure to complete a death certificate when they are unsure of a patient’s cause of death.

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, tod ...